Barely Significant
← all excerpts

Off-Label Use of Teriparatide in Spine.

Cureus · 2021 · PMC8376240 · PMID 34430132

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a strong trendp = 0.07so close (0.05 < p ≤ 0.1)
Radiographically, in comparison to calcitonin, there was a strong trend towards teriparatide for higher fusion rates (86.7% vs 56.3%, p = 0.07) [ 21 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.